Department of Medical Sciences, Cardiology, Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.
Department of Cardiology and Clinical Physiology, Uppsala University Hospital, Uppsala, Sweden.
Clin Res Cardiol. 2023 Jan;112(1):68-74. doi: 10.1007/s00392-022-02031-0. Epub 2022 May 17.
Patients hospitalized with acute coronary syndrome (ACS) in Sweden routinely undergo an echocardiographic examination with assessment of left ventricular ejection fraction (LVEF). LVEF is a measurement widely used for outcome prediction and treatment guidance. The obtained LVEF is categorized as normal (> 50%) or mildly, moderately, or severely impaired (40-49, 30-39, and < 30%, respectively) and reported to the nationwide registry for ACS (SWEDEHEART). The purpose of this study was to determine the reliability of the reported LVEF values by validating them against an independent re-evaluation of LVEF.
A random sample of 130 patients from three hospitals were included. LVEF re-evaluation was performed by two independent reviewers using the modified biplane Simpson method and their mean LVEF was compared to the LVEF reported to SWEDEHEART. Agreement between reported and re-evaluated LVEF was assessed using Gwet's AC2 statistics.
Analysis showed good agreement between reported and re-evaluated LVEF (AC2: 0.76 [95% CI 0.69-0.84]). The LVEF re-evaluations were in agreement with the registry reported LVEF categorization in 86 (66.0%) of the cases. In 33 (25.4%) of the cases the SWEDEHEART-reported LVEF was lower than re-evaluated LVEF. The opposite relation was found in 11 (8.5%) of the cases (p < 0.005).
Independent validation of SWEDEHEART-reported LVEF shows an overall good agreement with the re-evaluated LVEF. However, a tendency towards underestimation of LVEF was observed, with the largest discrepancy between re-evaluated LVEF and registry LVEF in subjects with subnormal LV-function in whom the reported assessment of LVEF should be interpreted more cautiously.
在瑞典,因急性冠状动脉综合征(ACS)住院的患者通常会接受超声心动图检查,并评估左心室射血分数(LVEF)。LVEF 是一种广泛用于预后预测和治疗指导的测量方法。获得的 LVEF 分为正常(>50%)或轻度、中度、重度受损(分别为 40-49、30-39 和<30%),并报告给全国 ACS 登记处(SWEDEHEART)。本研究的目的是通过验证 LVEF 值与独立的 LVEF 再评估的相关性来确定报告的 LVEF 值的可靠性。
从三家医院中随机抽取 130 名患者。LVEF 再评估由两名独立的审查员使用改良双平面 Simpson 法进行,他们的平均 LVEF 与 SWEDEHEART 报告的 LVEF 进行比较。使用 Gwet 的 AC2 统计数据评估报告的 LVEF 与重新评估的 LVEF 之间的一致性。
分析显示,报告的 LVEF 与重新评估的 LVEF 之间存在良好的一致性(AC2:0.76 [95%CI 0.69-0.84])。在 86 例(66.0%)病例中,LVEF 再评估与登记处报告的 LVEF 分类一致。在 33 例(25.4%)病例中,SWEDEHEART 报告的 LVEF 低于重新评估的 LVEF。在 11 例(8.5%)病例中发现相反的关系(p<0.005)。
对 SWEDEHEART 报告的 LVEF 进行独立验证显示,与重新评估的 LVEF 总体上具有良好的一致性。然而,观察到 LVEF 存在低估的趋势,在左心室功能异常的患者中,重新评估的 LVEF 与登记处 LVEF 之间的差异最大,因此对这些患者的 LVEF 评估应更谨慎地解读。